Anaxomics is a service provider company addressed to speed up drug discovery, preclinical and clinical development. Our artificial intelligence (AI) based proprietary technology (TPMS), allows the computational simulation of human pathophysiology. Interestingly, the exploitation of these mathematical models of patients allows the performance of different in silico analyses: Drug head-to-head comparison, drug repositioning, mechanism of action identification, patient stratification, therapeutic target discovery, in Silico clinical trial testing. Our services encompass the whole drug development process, ranging from the early drug discovery steps to the later clinical stages.
Last time updated September 2021